Sorry, you need to enable JavaScript to visit this website.
Skip to main content
REPORT

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
CT -  Taipei City
CT -  Taipei City
TH -  Bangkok
NZ -  New Zealand
KR -  Seoul (Gangnam)
KR -  Gyeonggi-do
KR -  Seoul City Airport

North America

US -  Boston
US -  Charleston

GLOBAL

English

CAREERS

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
CT -  Taipei City
CT -  Taipei City
TH -  Bangkok
NZ -  New Zealand
KR -  Seoul (Gangnam)
KR -  Gyeonggi-do
KR -  Seoul City Airport

North America

US -  Boston
US -  Charleston

GLOBAL

English

Clinical trial landscape of t-cell lymphomas in asia-pacific

T-cell lymphomas (TCLs) are types of non-Hodgkin’s lymphoma (NHL) that affect T lymphocytes.  About 10% of NHLs are TCLs, with this proportion reaching over 30% in certain Asian locations. The Asia region shows high rates of subtypes such as extranodal NK/T-cell lymphoma (ENKTL), hydroa vacciniforme-like lymphoma (HVL), subcutaneous panniculitis T-cell lymphoma (SPTCL), and adult T-cell leukemia/lymphoma [6], with a prevalence 15% higher compared with Western countries.

By downloading, you confirm that you agree to the storing and processing of your personal data as described in our Privacy Statement.